AdaptHealth (AHCO) Cash from Financing Activities (2018 - 2026)

AdaptHealth's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $52.6 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 193.8% year-over-year to $52.6 million; the TTM figure through Mar 2026 stood at -$193.6 million (up 34.66% YoY), while the FY2025 annual figure was -$302.2 million, down 51.89% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $52.6 million, up from -$32.9 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $52.6 million in Q1 2026, with the low at -$156.6 million in Q2 2025.
• The 5-year median for Cash from Financing Activities is -$32.9 million (2025), against an average of -$35.7 million.
• Peak annual rise in Cash from Financing Activities reached 828.28% in 2024, while the deepest fall reached 458.1% in 2024.
• AdaptHealth's Cash from Financing Activities stood at -$15.6 million in 2022, then sank by 181.32% to -$43.9 million in 2023, then fell by 23.06% to -$54.0 million in 2024, then surged by 38.98% to -$32.9 million in 2025, then surged by 259.58% to $52.6 million in 2026.
• Business Quant data shows AHCO's Cash from Financing Activities at $52.6 million in Q1 2026, -$32.9 million in Q4 2025, and -$56.6 million in Q3 2025.